Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 560.70
Change Today -3.00 / -0.53%
Volume 29.2K
PLX On Other Exchanges
Symbol
Exchange
NYSE Amex
Frankfurt
Tel Aviv
As of 10:24 AM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Yoseph Shaaltiel Ph.D.

Founder and Executive Vice President of Research & Development,Protalix BioTherapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

61$775,897
As of Fiscal Year 2014

Background*

Mr. Yoseph Shaaltiel, Ph.D founded Protalix BioTherapeutics, Inc. in 1993 and has been its Executive Vice President of Research and Development since December 2006. Dr. Shaaltiel served as a Vice President Research and Development at Protalix BioTherapeutics, Inc. since December 31, 2006. Previously, Dr. Shaaltiel served as Research Associate at the MIGAL Technological Center. He also served as Deputy Head of the Biology Department of the Biological and Chemical Center ...

Read Full Background

Corporate Headquarters*

2 Snunit Street
Carmiel, -- 21000

Israel

Phone: 972 4 988 9488
Fax: 972 4 988 9489

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MS
Hebrew University of Jerusalem
PhD
Weizmann Institute Of Science
BS
Ben-Gurion University

Other Affiliations*

Annual Compensation*

Salary$305,548
Bonus$90,000
Total Annual Compensation$395,548

Stock Options*

Restricted Stock Awards$232,979
All Other Compensation$84,719
Exercisable Options556,723
Unexercisable Options24,167
Total Number of Options580,890

Total Compensation*

Total Annual Cash Compensation$480,267
Total Short Term Compensation$395,548
Other Long Term Compensation$317,698
Total Calculated Compensation$775,897
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PLX:IT 560.70 -3.00

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PROTALIX BIOTHERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.